Literature DB >> 29193566

Systematic review and meta-analysis of algorithms used to identify drug-induced liver injury (DILI) in health record databases.

Eng Hooi Tan1, En Xian Sarah Low2, Yock Young Dan2,3, Bee Choo Tai1,4.   

Abstract

BACKGROUND & AIMS: Drug induced liver injury (DILI) is largely underreported, leading to underestimation of its burden. Electronic detection of DILI in healthcare databases shows promise to overcome the issues of spontaneous reporting. The performance of detection algorithms may vary because of inconsistent DILI definition and detection criteria. We performed a systematic review and meta-analysis to identify the DILI detection criteria used in health record databases and determine the performance characteristics of the detection algorithms.
METHODS: We searched PubMed, EMBASE and Scopus for studies that utilized laboratory threshold criteria to identify DILI cases. Validation studies were included in the meta-analysis. Data were abstracted using standardized forms and quality was assessed using modified Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) criteria. We evaluate the performance characteristics of the detection algorithm by obtaining the pooled estimate of the positive predictive value (PPV) assuming a random effects model.
RESULTS: A total of 29 studies met the inclusion criteria for the systematic review; 25 of these studies (n = 35 948) had PPV estimates for performing the meta-analysis. The PPV of DILI detection algorithms was low, ranging from 1.0% to 40.2%, with a pooled estimate of 14.6% (95% CI 10.7-18.9). Algorithms that performed better had prespecified exclusion diagnoses as well as drugs of interest to minimize false positives.
CONCLUSION: Algorithm performance varied with different case definitions of DILI attributed to different laboratory threshold criteria, diagnosis codes, and study drugs.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  algorithm; drug induced liver injury; health record database; positive predictive value

Mesh:

Year:  2017        PMID: 29193566     DOI: 10.1111/liv.13646

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  10 in total

1.  Utility of a Computerized ICD-10 Algorithm to Identify Idiosyncratic Drug-Induced Liver Injury Cases in the Electronic Medical Record.

Authors:  Amoah Yeboah-Korang; Jeremy Louissaint; Irene Tsung; Sharmila Prabhu; Robert J Fontana
Journal:  Drug Saf       Date:  2020-04       Impact factor: 5.606

2.  Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.

Authors:  Jeremy Louissaint; Ihab Kassab; Amoah Yeboah-Korang; Robert J Fontana
Journal:  Dig Dis Sci       Date:  2021-08-24       Impact factor: 3.487

Review 3.  The diagnostic role of miR-122 in drug-induced liver injury: A systematic review and meta-analysis.

Authors:  Yiqi Liu; Ping Li; Liang Liu; Yilian Zhang
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

4.  Guidance for the clinical evaluation of traditional Chinese medicine-induced liver injuryIssued by China Food and Drug Administration.

Authors:  Xiaohe Xiao; Jianyuan Tang; Yimin Mao; Xiuhui Li; Jiabo Wang; Chenghai Liu; Kewei Sun; Yong'an Ye; Zhengsheng Zou; Cheng Peng; Ling Yang; Yuming Guo; Zhaofang Bai; Tingting He; Jing Jing; Fengyi Li; Na An
Journal:  Acta Pharm Sin B       Date:  2018-12-14       Impact factor: 11.413

5.  Validity of ICD-9 and ICD-10 codes used to identify acute liver injury: A study in three European data sources.

Authors:  Joan Forns; Miguel Cainzos-Achirica; Maja Hellfritzsch; Rosa Morros; Beatriz Poblador-Plou; Jesper Hallas; Maria Giner-Soriano; Alexandra Prados-Torres; Anton Pottegård; Jordi Cortés; Jordi Castellsagué; Emmanuelle Jacquot; Nicolas Deltour; Susana Perez-Gutthann; Manel Pladevall
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-06-06       Impact factor: 2.890

Review 6.  Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future.

Authors:  Gaby Danan; Rolf Teschke
Journal:  Front Pharmacol       Date:  2019-07-29       Impact factor: 5.810

Review 7.  Idiosyncratic DILI: Analysis of 46,266 Cases Assessed for Causality by RUCAM and Published From 2014 to Early 2019.

Authors:  Rolf Teschke
Journal:  Front Pharmacol       Date:  2019-07-23       Impact factor: 5.810

8.  Active Pharmacovigilance of Drug-Induced Liver Injury Using Electronic Health Records.

Authors:  Sang Heon Kim
Journal:  Allergy Asthma Immunol Res       Date:  2020-05       Impact factor: 5.764

9.  Evaluation of Drug-Induced Liver Injury Developed During Hospitalization Using Electronic Health Record (EHR)-Based Algorithm.

Authors:  Yewon Kang; Sae Hoon Kim; So Young Park; Bo Young Park; Ji Hyang Lee; Jin An; Ha Kyeong Won; Woo Jung Song; Hyouk Soo Kwon; You Sook Cho; Hee Bom Moon; Ju Hyun Shim; Min Suk Yang; Tae Bum Kim
Journal:  Allergy Asthma Immunol Res       Date:  2020-05       Impact factor: 5.764

10.  Using an Automated Algorithm to Identify Potential Drug-Induced Liver Injury Cases in a Pharmacovigilance Database.

Authors:  Liliam Pineda Salgado; Ritu Gupta; Michael Jan; Osman Turkoglu; Alvin Estilo; Vinu George; Mirza I Rahman
Journal:  Adv Ther       Date:  2021-07-28       Impact factor: 3.845

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.